Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Cybin Inc. Common Stock

Cybin Inc. Common Stock (HELP) Stock Overview

Explore Cybin Inc. Common Stock’s financial performance, market position, analyst ratings, and future outlook.

HELP●NASDAQ
HealthcareMedical - Pharmaceuticals
$13.66
$1.29(10.43%)
U.S. Market opens in 3h 24m

Cybin Inc. Common Stock (HELP)

Meyka AI Score

Z

Key Financials

Market Cap846.7M
P/E Ratio-2.53
EPS (TTM)$-4.16
ROE-0.71%
Fundamental Analysis

AI Price Forecasts

1 Month$9.52
3 Months$11.71
1 Year Target$11.59

HELP Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Cybin Inc. Common Stock (NASDAQ: HELP) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Cybin Inc. Common Stock's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of HELP on the NASDAQ shows an RSI of 58.56, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $11.59 for the NASDAQ listing.

Key metrics behind Cybin Inc. Common Stock's NASDAQ-traded stock include a P/E ratio of -2.53 and a market capitalization of 846.7M. Combined with our AI analysis, these give both institutional and retail investors a clear view of HELP on the NASDAQ.

Price Performance (NASDAQ: HELP)

1-Day Change
10.43%
5-Day Change
2.71%
1-Month Change
8.50%
3-Month Change
181.65%
6-Month Change
195.67%
Year-to-Date (YTD) Change
66.99%
1-Year Change
131.13%
3-Year Change
131.13%
5-Year Change
131.13%
All-Time (Max) Change
131.13%

Contact Information

https://www.helus.com
908 764 8385
100 King Street West, Suite 5600, Toronto, ON, M5X 1C9

Company Facts

1,000 Employees
IPO DateSep 13, 2019
CountryCA
Actively Trading

Frequently Asked Questions